Condition
Lymphangiosarcoma
Oncology
Overview
A malignant tumor originating from the endothelial cells of lymphatic vessels. Most lymphangiosarcomas arise in an arm secondary to radical mastectomy but they sometimes complicate idiopathic lymphedema. The lymphedema has usually been present for 6 to 10 years before malignant changes develop. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p1866)
This information is general and should not be treated as medical advice. Always speak directly with a qualified healthcare professional before making decisions about treatment, diagnosis, procedures, medicines or care.
Quick facts about Lymphangiosarcoma
- Topic type
- Condition
- Category
- Oncology
- MeSH classification
- C04.557.375.480|C04.557.450.795.480
Preparing for an appointment about Lymphangiosarcoma
If you are speaking with a healthcare professional about Lymphangiosarcoma, it can help to prepare a few details in advance.
- Write down your symptoms and when they started.
- Bring details of any medicines, supplements or previous treatments.
- Ask what tests or assessments may be needed.
- Ask what treatment or management options may be suitable.
- Ask when you should seek urgent medical help or follow-up care.
Finding care related to Lymphangiosarcoma
EuroCareFinder helps patients explore clinics and healthcare providers across Europe. Some topics link directly to services offered by clinics, while others may be connected through related specialties, treatments or procedures.
Explore clinics across Europe
Browse the wider EuroCareFinder healthcare network using the interactive map.
Clinics related to Lymphangiosarcoma
No clinics are currently linked directly to Lymphangiosarcoma on EuroCareFinder.
As more clinics add detailed services, related providers may appear here.
Related topics
Explore healthcare providers
Use EuroCareFinder to browse clinics by country, specialty and available services.
Source: Medical Subject Headings (MeSH), produced by the U.S. National Library of Medicine. EuroCareFinder is not endorsed by the National Library of Medicine. MeSH version: 2026.